Copyright Reports & Markets. All rights reserved.

Global Tissue Microarray Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Tissue Microarray
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Tissue Microarray by Type
    • 1.3.1 Overview: Global Tissue Microarray Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Tissue Microarray Consumption Value Market Share by Type in 2023
    • 1.3.3 Immunohistochemistry
    • 1.3.4 Fluorescent In-Situ Hybridization
    • 1.3.5 Frozen Tissue Array
    • 1.3.6 Others
  • 1.4 Global Tissue Microarray Market by Application
    • 1.4.1 Overview: Global Tissue Microarray Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Pharmaceutical and Biotechnological Companies
    • 1.4.3 Research Organization
    • 1.4.4 Others
  • 1.5 Global Tissue Microarray Market Size & Forecast
  • 1.6 Global Tissue Microarray Market Size and Forecast by Region
    • 1.6.1 Global Tissue Microarray Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Tissue Microarray Market Size by Region, (2019-2030)
    • 1.6.3 North America Tissue Microarray Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Tissue Microarray Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Tissue Microarray Market Size and Prospect (2019-2030)
    • 1.6.6 South America Tissue Microarray Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Tissue Microarray Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Bio-Techne
    • 2.1.1 Bio-Techne Details
    • 2.1.2 Bio-Techne Major Business
    • 2.1.3 Bio-Techne Tissue Microarray Product and Solutions
    • 2.1.4 Bio-Techne Tissue Microarray Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Bio-Techne Recent Developments and Future Plans
  • 2.2 Applied Microarrays
    • 2.2.1 Applied Microarrays Details
    • 2.2.2 Applied Microarrays Major Business
    • 2.2.3 Applied Microarrays Tissue Microarray Product and Solutions
    • 2.2.4 Applied Microarrays Tissue Microarray Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Applied Microarrays Recent Developments and Future Plans
  • 2.3 Z Biotech
    • 2.3.1 Z Biotech Details
    • 2.3.2 Z Biotech Major Business
    • 2.3.3 Z Biotech Tissue Microarray Product and Solutions
    • 2.3.4 Z Biotech Tissue Microarray Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Z Biotech Recent Developments and Future Plans
  • 2.4 OriGene
    • 2.4.1 OriGene Details
    • 2.4.2 OriGene Major Business
    • 2.4.3 OriGene Tissue Microarray Product and Solutions
    • 2.4.4 OriGene Tissue Microarray Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 OriGene Recent Developments and Future Plans
  • 2.5 BioCat
    • 2.5.1 BioCat Details
    • 2.5.2 BioCat Major Business
    • 2.5.3 BioCat Tissue Microarray Product and Solutions
    • 2.5.4 BioCat Tissue Microarray Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 BioCat Recent Developments and Future Plans
  • 2.6 Bio SB
    • 2.6.1 Bio SB Details
    • 2.6.2 Bio SB Major Business
    • 2.6.3 Bio SB Tissue Microarray Product and Solutions
    • 2.6.4 Bio SB Tissue Microarray Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Bio SB Recent Developments and Future Plans
  • 2.7 Creative Bioarray
    • 2.7.1 Creative Bioarray Details
    • 2.7.2 Creative Bioarray Major Business
    • 2.7.3 Creative Bioarray Tissue Microarray Product and Solutions
    • 2.7.4 Creative Bioarray Tissue Microarray Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Creative Bioarray Recent Developments and Future Plans
  • 2.8 Abcam
    • 2.8.1 Abcam Details
    • 2.8.2 Abcam Major Business
    • 2.8.3 Abcam Tissue Microarray Product and Solutions
    • 2.8.4 Abcam Tissue Microarray Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Abcam Recent Developments and Future Plans
  • 2.9 BioIVT
    • 2.9.1 BioIVT Details
    • 2.9.2 BioIVT Major Business
    • 2.9.3 BioIVT Tissue Microarray Product and Solutions
    • 2.9.4 BioIVT Tissue Microarray Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 BioIVT Recent Developments and Future Plans
  • 2.10 Externautics
    • 2.10.1 Externautics Details
    • 2.10.2 Externautics Major Business
    • 2.10.3 Externautics Tissue Microarray Product and Solutions
    • 2.10.4 Externautics Tissue Microarray Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Externautics Recent Developments and Future Plans
  • 2.11 Protein Biotechnologies
    • 2.11.1 Protein Biotechnologies Details
    • 2.11.2 Protein Biotechnologies Major Business
    • 2.11.3 Protein Biotechnologies Tissue Microarray Product and Solutions
    • 2.11.4 Protein Biotechnologies Tissue Microarray Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Protein Biotechnologies Recent Developments and Future Plans
  • 2.12 US Biomax Inc.
    • 2.12.1 US Biomax Inc. Details
    • 2.12.2 US Biomax Inc. Major Business
    • 2.12.3 US Biomax Inc. Tissue Microarray Product and Solutions
    • 2.12.4 US Biomax Inc. Tissue Microarray Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 US Biomax Inc. Recent Developments and Future Plans
  • 2.13 Auria Biopankki
    • 2.13.1 Auria Biopankki Details
    • 2.13.2 Auria Biopankki Major Business
    • 2.13.3 Auria Biopankki Tissue Microarray Product and Solutions
    • 2.13.4 Auria Biopankki Tissue Microarray Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Auria Biopankki Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Tissue Microarray Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Tissue Microarray by Company Revenue
    • 3.2.2 Top 3 Tissue Microarray Players Market Share in 2023
    • 3.2.3 Top 6 Tissue Microarray Players Market Share in 2023
  • 3.3 Tissue Microarray Market: Overall Company Footprint Analysis
    • 3.3.1 Tissue Microarray Market: Region Footprint
    • 3.3.2 Tissue Microarray Market: Company Product Type Footprint
    • 3.3.3 Tissue Microarray Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Tissue Microarray Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Tissue Microarray Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Tissue Microarray Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Tissue Microarray Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Tissue Microarray Consumption Value by Type (2019-2030)
  • 6.2 North America Tissue Microarray Consumption Value by Application (2019-2030)
  • 6.3 North America Tissue Microarray Market Size by Country
    • 6.3.1 North America Tissue Microarray Consumption Value by Country (2019-2030)
    • 6.3.2 United States Tissue Microarray Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Tissue Microarray Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Tissue Microarray Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Tissue Microarray Consumption Value by Type (2019-2030)
  • 7.2 Europe Tissue Microarray Consumption Value by Application (2019-2030)
  • 7.3 Europe Tissue Microarray Market Size by Country
    • 7.3.1 Europe Tissue Microarray Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Tissue Microarray Market Size and Forecast (2019-2030)
    • 7.3.3 France Tissue Microarray Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Tissue Microarray Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Tissue Microarray Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Tissue Microarray Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Tissue Microarray Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Tissue Microarray Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Tissue Microarray Market Size by Region
    • 8.3.1 Asia-Pacific Tissue Microarray Consumption Value by Region (2019-2030)
    • 8.3.2 China Tissue Microarray Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Tissue Microarray Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Tissue Microarray Market Size and Forecast (2019-2030)
    • 8.3.5 India Tissue Microarray Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Tissue Microarray Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Tissue Microarray Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Tissue Microarray Consumption Value by Type (2019-2030)
  • 9.2 South America Tissue Microarray Consumption Value by Application (2019-2030)
  • 9.3 South America Tissue Microarray Market Size by Country
    • 9.3.1 South America Tissue Microarray Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Tissue Microarray Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Tissue Microarray Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Tissue Microarray Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Tissue Microarray Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Tissue Microarray Market Size by Country
    • 10.3.1 Middle East & Africa Tissue Microarray Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Tissue Microarray Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Tissue Microarray Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Tissue Microarray Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Tissue Microarray Market Drivers
  • 11.2 Tissue Microarray Market Restraints
  • 11.3 Tissue Microarray Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Tissue Microarray Industry Chain
  • 12.2 Tissue Microarray Upstream Analysis
  • 12.3 Tissue Microarray Midstream Analysis
  • 12.4 Tissue Microarray Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Tissue Microarray market size was valued at USD 6766 million in 2023 and is forecast to a readjusted size of USD 10000 million by 2030 with a CAGR of 5.7% during review period.
    Tissue Microarray (TMA) refers to the innovative practice of relocating multiple tissues sections from conventional histologic paraffin blocks so that the tissues from multiple samples can be observed on the same slide.It is a novel and useful tool to efficiently analyze gene expression in histological tissues.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    The Global Info Research report includes an overview of the development of the Tissue Microarray industry chain, the market status of Pharmaceutical and Biotechnological Companies (Immunohistochemistry, Fluorescent In-Situ Hybridization), Research Organization (Immunohistochemistry, Fluorescent In-Situ Hybridization), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Tissue Microarray.
    Regionally, the report analyzes the Tissue Microarray markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Tissue Microarray market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Tissue Microarray market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Tissue Microarray industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Immunohistochemistry, Fluorescent In-Situ Hybridization).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Tissue Microarray market.
    Regional Analysis: The report involves examining the Tissue Microarray market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Tissue Microarray market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Tissue Microarray:
    Company Analysis: Report covers individual Tissue Microarray players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Tissue Microarray This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pharmaceutical and Biotechnological Companies, Research Organization).
    Technology Analysis: Report covers specific technologies relevant to Tissue Microarray. It assesses the current state, advancements, and potential future developments in Tissue Microarray areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Tissue Microarray market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Tissue Microarray market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
    Market segment by Type
    Immunohistochemistry
    Fluorescent In-Situ Hybridization
    Frozen Tissue Array
    Others
    Market segment by Application
    Pharmaceutical and Biotechnological Companies
    Research Organization
    Others
    Market segment by players, this report covers
    Bio-Techne
    Applied Microarrays
    Z Biotech
    OriGene
    BioCat
    Bio SB
    Creative Bioarray
    Abcam
    BioIVT
    Externautics
    Protein Biotechnologies
    US Biomax Inc.
    Auria Biopankki
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Tissue Microarray product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Tissue Microarray, with revenue, gross margin and global market share of Tissue Microarray from 2019 to 2024.
    Chapter 3, the Tissue Microarray competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Tissue Microarray market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Tissue Microarray.
    Chapter 13, to describe Tissue Microarray research findings and conclusion.

    Buy now